| ||||||
| ||||||
The Deal Economy 2010
When: November 18 & 19, 2009 Over past decades, corporate and financial dealmakers have weathered difficult cycles only to emerge stronger once the storm has past. But this time, the economic challenges confronting investors are unlike any other era. Uncertainty is the new normal. Once this downturn has played itself out, all agree a very different deal-making world awaits us. Massive government bailouts and interventions in financial markets worldwide have levied major changes on Wall Street, but, so far, have provided limited stimuli to deal activity. Frozen credit markets have all but smothered any private equity deals, forcing the buyout industry to search for new models and approaches to generate returns. Cash-rich strategics are on the prowl but in many cases, remain reluctant to pounce. As the distressed cycle ticks up, businesses, assets and debt have kept opportunistic dealmakers with an appetite for risk active and in the spotlight. Over the course of The Deal's annual two-day outlook forecasting conference, respected corporate dealmakers, alternative investors and leading advisers and intermediaries to transactions will discuss and debate the new deal-making landscape and prospects for deal opportunities in 2010. Join us and them in New York for unrivalled perspective to help you plan.
Who Should Attend?
• CFOs, CDOs and heads of M&A at global 1000s
For more information about sponsorship and exhibitor opportunities,  Video highlights from M&A Outlook
More video coverage
Complete archive from The Deal VideoEditorial coverage from last year's eventMcKinsey explores decline and recovery in past recessionsfrom Corporate Dealmaker
Sometimes the best indicators of the way forward can be found by looking back, which is why "Mapping Decline and Recovery Across Sectors," is worth a read. The report published in the latest McKinsey Quarterly (registration required) analyzes the financial... More quietly hostile deals in 2009from Corporate Dealmaker
As Thomas Zadvydas reported Wednesday on TheDeal.com (subscription required), Sequenom Inc. is going hostile with its $41 million offer for rival Exact Sciences Corp. The medical research firm decided to take the offer directly to Exact Sciences' shareholders after the... M&A Outlook 2009: Georgetown's Pitofsky on antitrust under Obama's administrationfrom Dealscape
At The Deal's M&A Outloook 2009 conference, Robert Pitofsky, professor of antitrust and trade at Georgetown University, addressed how antitrust enforcement will change during the Obama administration. See the video after the break or download it at iTunes.- Maria Woehr... M&A Outlook 2009: Barclays' Parker on critical-care M&Afrom Dealscape
At The Deal's M&A Outlook 2009 conference, Paul Parker, managing director and chairman and head of Global M&A at Barclays Capital, explained that M&A is difficult right now because it's hard to pin down a valuation on a company due... M&A Outlook 2009: Carlyle's Marchick on modernizing the regulatory structurefrom Dealscape
At The Deal's M&A Outlook 2009 conference, David Marchick, managing director of global government and regulatory affairs at the Carlyle Group, spoke about how President-elect Barack Obama's administration will modernize the regulatory structure. See the video after the break or... M&A Outlook 2009: Blue Wolf's Blumenthal on regulationfrom Dealscape
At The Deal's M&A Outlook 2009 conference, Adam Blumenthal, a portfolio manager at Blue Wolf Capital Management LLC, said he believes that the government has to question everything as it alters the regulatory structure of financial institutions because it is... M&A Outlook 2009: Barclays' Parker on the historical perspective of the recessionfrom Dealscape
At The Deal's M&A Outlook 2009 conference, Paul Parker, managing director and chairman of Global M&A at Barclays Capital, took a look at the recession and crisis on Wall Street from an historical perspective. "While we have never seen such... M&A Outlook 2009: Foley's Rothman and Guardian's Turner on 2009 middle-market transactionsfrom Dealscape
At the Deal's M&A Outlook 2009 conference, dealmakers Jay Rothman, a partner at Foley & Lardner LLP, and David Turner, managing director, head of private equity at Guardian, debated the M&A outlook for the middle market in 2009. Rothman argued... M&A Outlook 2009: Rothman and Peskoff on middle market valuationsfrom Dealscape
At The Deal's M&A Outlook 2009 Jay Rothman, a partner at Foley & Lardner LLP, and Jonathan Peskoff, managing director of investment banking M&A Group at FBR Capital Markets, said it could take two quarters before valuations of middle market... M&A Outlook 2009: Lazard's Parr on Lehman Brothers' failurefrom Dealscape
The economic storm is far from over explains Lazard deputy chairman Gary Parr and H. Rodgin Cohen, chairman of Sullivan & Cromwell LLP, at The Deal's M&A Outlook 2009 conference. In this video the two dealmakers discuss how Lehman Brothers... M&A Outlook 2009: Goldstein on SPACsfrom Dealscape
Phillip Goldstein, a principal at hedge fund Bulldog Investors, was the keynote interview at The Deal's M&A Outlook 2009 conference. In this video Goldstein says there is a lot of activism in SPACs in this market because there is "virtually... M&A Outlook 2009: Linklaters' Rees on why sovereign wealth funds investments have slowedfrom Dealscape
At the Deal's M&A Outlook 2009 conference, Nick Rees, a co-managing partner corporate and M&A group of Linklaters LLP, said investments from sovereign wealth funds have slowed down. "They have been less active than we all thought they would... Complete archive from Dealscape 
 
|
|
|
|
|
|
